Pin Oak Equity
Pin Oak Equity is an all-cap equity fund that focuses on companies with attractive valuation and strong competitive advantages. The Fund concentrates in a select number of sectors and holdings; it seeks the Manager’s best ideas, regardless of company’s size.
Inception Date
Aug 03 1992Number of Holdings
26Investment Goal
Pin Oak Equity Fund seeks long-term capital growth.
Investment Approach
Our investment process is both top-down and bottom-up; the process involves identifying what we believe to be the most attractive sectors and then narrowing the search to individual stocks, where we employ both quantitative and qualitative factors. The Manager focuses on the long-term merits of an investment, placing significant weight on the durability of the business and the company’s valuation. Perhaps the greatest asset of the fund is the longer time horizon – relative to other market participants. An increasingly short-term oriented market affords greater opportunity for long-term investors, especially when the manager is willing to concentrate in a limited number of sectors and hold out-of-consensus positions. We believe that focusing on the long-term, emphasizing what matters (durability and valuation), and being willing to go against the crowd give us the best chance to outperform the benchmark and our peers over the long-term.
Literature
|
Pin Oak Factsheet
|
View PDF |
|
Pin Oak Summary Prospectus
|
View PDF |
|
Annual Report
|
View PDF |
|
Semi-Annual Report
|
View PDF |
|
Statutory Prospectus
|
View PDF |
|
Statement of Additional Information (SAI)
|
View PDF |
Fund Performance
| POGSX | Morningstar US Market Index | |
|---|---|---|
| 1 Year | 10.56 | 20.90 |
| 3 Year | 9.83 | 14.63 |
| 5 Year | 12.72 | 15.52 |
| 10 Year | 12.88 | 13.90 |
| Inception Date | Aug 03, 1992 |
| POGSX | Morningstar US Market Index | |
|---|---|---|
| 1 Year | 10.56 | 20.90 |
| 3 Year | 9.83 | 14.63 |
| 5 Year | 12.72 | 15.52 |
| 10 Year | 12.88 | 13.90 |
| Inception Date | Aug 03, 1992 |
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an Investor’s shares, when redeemed, may not be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. For performance data current to the most recent month end, please call 1-888-462-5386.
Pin Oak Equity Fund ("the Fund") is not sponsored, endorsed, sold or promoted by Morningstar, Inc. or any of its affiliates (all such entities, collectively, "Morningstar Entities"). The Morningstar Entities make no representation or warranty, express or implied, to individuals who invest in the Fund or any member of the public regarding the advisability of investing in equity securities generally or in the Fund in particular or the ability of the Fund to track the Morningstar U.S. Index or general equity market performance. THE MORNINGSTAR ENTITIES DO NOT GUARANTEE THE ACCURACY AND/OR THE COMPLETENESS OF PIN OAK EQUITY OR ANY DATA INCLUDED THEREIN AND MORNINGSTAR ENTITIES SHALL HAVE NO LIABILITY FOR ANY ERRORS, OMISSIONS, OR INTERRUPTIONS THEREIN. One cannot invest directly in an index.
Daily
Closing price as of 01/22/2021| Share Price | $82.65 |
| Change | -0.24% |
| Year-to-Date Performance | +5.13% |
Fund Managers
Portfolio Manager
experience
with Oak
Portfolio Holdings
As of Dec 31, 2020
| Holding | Ticker | |
|---|---|---|
| 9.6 | Alphabet, Inc. | GOOG |
| 9.1 | Amazon.com, Inc. | AMZN |
| 6.7 | KLA-Tencor Corp. | KLAC |
| 6.4 | Xilinx, Inc. | XLNX |
| 5.9 | Charles Schwab Corp./The | SCHW |
| 5.4 | Gentex Corp. | GNTX |
| 4.8 | Illumina, Inc. | ILMN |
| 4.4 | eBay, Inc. | EBAY |
| 3.9 | Alphabet, Inc. | GOOGL |
| 3.6 | Facebook, Inc. | FB |
| 3.6 | Intuitive Surgical, Inc. | ISRG |
| 3.5 | DraftKings, Inc. | DKNG |
| 3.5 | McKesson Corp. | MCK |
| 3.4 | PayPal Holdings, Inc. | PYPL |
| 3.4 | Visa, Inc. | V |
| 3.2 | Amdocs Ltd. | DOX |
| 3.2 | Medtronic PLC | MDT |
| 2.9 | Assurant, Inc. | AIZ |
| 2.3 | Amgen, Inc. | AMGN |
| 2.3 | Bank of New York Mellon Corp./The | BK |
| 2.2 | GlaxoSmithKline PLC | GSK |
| 2.2 | Paychex, Inc. | PAYX |
| 1.4 | Everest Re Group Ltd. | RE |
| 1.2 | Gilead Sciences, Inc. | GILD |
| 1.0 | Quest Diagnostics, Inc. | DGX |
| 0.9 | Biogen, Inc. | BIIB |